Neuroblastoma trials in Russia

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma

  Where

  Moscow

  Age

  18 months to 18 years

  People

  5

  Run by

  Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  See details and how to joinNCT07375563
• No phaseTaking people
  Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification

  Where

  Moscow

  Age

  1 day to 18 years

  People

  200

  Run by

  Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  See details and how to joinNCT06296732
• Phase 3Taking people
  Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma

  Where

  Moscow

  Age

  18 months to 18 years

  People

  15

  Run by

  Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  See details and how to joinNCT06071897